Bath & Body Works is trading 4.04% down at $18.39, with no clearly reported company-specific catalyst explaining the August 25, 2026 decline.

  • The broader market is higher, and the move does not appear to be following index sentiment.
  • Investors are focused on second-quarter results due before market open on August 26.
  • Expectations are for $0.24 earnings per share and $1.5 billion in revenue amid ongoing sales pressure.